Clinical Trial Update: Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an NMDA enhancer for early intervention in prodromal schizophrenia, currently recruiting at China Medical University Hospita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NMDA enhancer (investigational)

Snippet

Sponsor: China Medical University Hospital | Conditions: Prodromal Schizophrenia | Phase 2 | Status: RECRUITING